Published Date:2024-04-22 Original Link:https://www.onenessbio.com/en/news_detail280_4.htm No 1 Date of announcement 2024/04/22 Time of announcement 18:16:38 Subject Subcutaneous injection formulation of FB825 to treat moderate-to-severe atopic dermatitis was greenlighted by TFDA to proceed with a Ph2 study To which item it meets paragraph 10 Date of events 2024/04/22 Statement Date of occurrence of the event:2024/04/22 New drug...Read More

Published Date:2024-03-29 Original Link:https://www.onenessbio.com/en/news_detail279_4.htm No 1 Date of announcement 2024/03/29 Time of announcement 18:08:07 Subject Submission of a phase II clinical trial protocol to Taiwan FDA for subcutaneous injection formulation of FB825 in patients with moderate-to-severe atopic dermatitis To which item it meets paragraph 10 Date of events 2024/03/29 Statement Date of occurrence of the...Read More

Published Date:2024-03-22 Original Link:https://www.onenessbio.com/en/news_detail278_4.htm No 1 Date of announcement 2024/03/22 Time of announcement 17:16:28 Subject Oneness announces the information about the investor’s conference of 2024 Q1. To which item it meets paragraph 12 Date of events 2024/03/29 Statement Date of institutional investor conference:2024/03/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More

Published Date:2024-03-19 Original Link:https://www.onenessbio.com/en/news_detail277_4.htm No 1 Date of announcement 2024/03/19 Time of announcement 18:29:34 Subject Oneness Biotech Co., Ltd. receives a Saudi Arabian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/03/19 Statement Date of occurrence of the event:2024/3/19...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail274_4.htm No 8 Date of announcement 2024/02/29 Time of announcement 17:45:14 Subject Announce the change of the internal audit officer. To which item it meets paragraph 8 Date of events 2024/02/29 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer,...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail273_4.htm No 7 Date of announcement 2024/02/29 Time of announcement 17:42:49 Subject The board of directors of the Company approved removal of the noncompete clause for managers. To which item it meets paragraph 21 Date of events 2024/02/29 Statement Date of the board of directors resolution: 2024/02/29 Name and title of the...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail272_4.htm No 6 Date of announcement 2024/02/29 Time of announcement 17:40:23 Subject Annouce the change of the spokesperson. To which item it meets paragraph 8 Date of events 2024/02/29 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail271_4.htm No 5 Date of announcement 2024/02/29 Time of announcement 17:35:11 Subject Annouce the change of the general manager. To which item it meets paragraph 6 Date of events 2024/02/29 Statement Date of the board of directors resolution or date of occurrence of the change: 2024/02/29 Position (Please enter chairperson or president/general...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail270_4.htm No 4 Date of announcement 2024/02/29 Time of announcement 17:18:22 Subject Oneness Board of Directors resolved to convene the Annual Shareholders’ Meeting of 2024. To which item it meets paragraph 17 Date of events 2024/02/29 Statement Date of the board of directors resolution: 2024/02/29 General shareholders’ meeting date: 2024/05/21 General shareholders’...Read More

Published Date:2024-02-29 Original Link:https://www.onenessbio.com/en/news_detail269_4.htm No 3 Date of announcement 2024/02/29 Time of announcement 17:05:27 Subject The Board of Directors resolved to the new common share issuance through the increase of capital by capitalization of capital surplus To which item it meets paragraph 11 Date of events 2024/02/29 Statement Date of the board of directors resolution:...Read More